Macrolides are bacteriostatic antibiotics which interfere with the pep
tidyltransfer function of the ribosome. We have investigated the molec
ular mechanisms underlying macrolide resistance in Mycobacterium smegm
atis, an eubacterium carrying two rRNA operons. Surprisingly, drug res
istance was associated not with alterations in ribosomal proteins, but
with a single point mutation in the peptidyltransferase region of one
of the two 23S RNA genes, i.e. A2058-->G or A2059-->G. This mutation
resulted in a heterozygous organism with a mutated and a wild-type rRN
A operon respectively. Reverse transcriptase sequencing indicated the
expression of both wild-type and mutated rRNAs. The mutated operon was
introduced into genetically engineered rrn(-) strains of M. smegmatis
carrying a single functional rRNA operon and into parental M. smegmat
is with two chromosomal rRNA operons, using gene transfer as well as g
ene replacement techniques. The results obtained demonstrate the domin
ant nature of resistance. As exemplified in our results on macrolide r
esistance, a complete set of genetic tools is now available, which all
ows questions of dominance vs. recessivity and gene dosage effects in
eubacterial ribosomal nucleic acids to be addressed experimentally in
vivo.